BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below. This paper was submitted to a another journal from BMJ but declined for publication following peer review. The authors addressed the reviewers' comments and submitted the revised paper to BMJ Open. The paper was subsequently accepted for publication at BMJ Open.
The manuscript is well written and the methodology, study objectives and potential impact and value of the project are clear and well defined. However, I suggest that before publication -still various changes and improvements required. I have classified these changes as "minor revisions" because a more fundamental revision of the paper will not be necessary. However, they still constitute a range of issues. Nevertheless, many of these are relatively minor points. I recommend that these issues will be sufficiently addressed -before the paper will be accepted for publication. I am willing to review a revision of the manuscript if necessary.
Here are my comments:
(1) "Perceptions" -the investigations of "perceptions" plays a central role in the paper, but the concept is not conceptualized. Does the term refer to attitudes, opinions, viewpoints, knowledge, values, understandings of medical concepts, moral considerations, scruples, situated understandings of ethics, embodied sensibilities, or interpretations of medical experiences (or any other). This should be clarified.
(2) Moreover, the "objects" of the perceptions that the project aims to review should be defined in greater detail. Or, to put it differently, the focus of the protocol should be sharpened. Let me explain this by referring to (i) the perceptions of "donors" and "donation" and (i) the perceptions about "stem cell research and developing therapies" (i) Perceptions of donors: -Which types of donors / donors of which types of tissues is the protocol referring to? There are obviously huge differences of donors (and the perceptions of donors) donating embryos and ova, or donors donating bone marrow, blood cells. Each of these forms of donation has its own challenges and set of ethical dilemmas. Will you review literature related to all of these forms of donation? (This would presumably be a review project in its own rights). A selection seems recommendable. This needs to be pointed out. (ii) Perceptions "about stem cell research and developing therapies"
It would be good to briefly clarify what exactly is meant by "stem cell research" and "developing therapies".
I am not only thinking about the more obvious distinction related to the use of different types of cells (embryos, fetuses, umbilical cord, iPS, various forms of somatic cells, etc) but also to perceptions of the different aspects of stem cell research (for example: perceptions of (cell, embryo, ova, etc.) donation; perceptions of the patenting of stem cells; perceptions of the establishing of commercial cell cultures, perceptions of benefit sharing or social justice (or injustice), perceptions of the transfer of tissues from one person into the body of another person, etc.) And if you speak about "developing therapies" are you referring to formalized (officially approved) forms of clinical studies, experimental commercial interventions (offered maybe in legal grey areas), or the therapeutic use of cellular products that have already been recognized as "proven" therapeutic products).
I do not mean to suggest that this protocol paper is the place to discuss all the nuances or different aspects of stem cell research from basic science to clinical applications. However, what I mean is -be more specific and sharpen the focus -by defining more clearly which aspects of "stem cell research and developing therapies" the project and review will address. These issues could be addressed (for example) in the methodology section.
(3) The geographic dimensions of perceptions of SCR and therapies Clarification of the geographic focus of the study seems appropriate and necessary. Rather than stating -we focus on studies published in Chinese, English, Spanish and Slovenian -I suggest to say: "we include studies that have examined perceptions of SCR and therapies in the following countries: country a, b, c, etc. This is not only more accurate but it also avoids ambiguities (for example, literature in Chinese can both refer to empirical studies in China, Taiwan, Hong Kong, Singapore, but potentially also any other part of the world).
Once you have clearly stated which countries are represented in the review, you can still state that selection of texts is base on language expertise, and that this has produced limitations (or alternatively strengths, because not many researchers work with texts published in four languages).
(4) It is not clear to me -whether the research that is described in this project has already been completed, or whether it is still ongoing. Information from the following recent special could be relevant:
Rosemann, A., Barfoot, J., and C. Blackburn To sum up: I do think this protocol paper should be published, after addressing the above points. In essence many of the issues are raised do not require much work. I would like to wish the authors the best of luck with their revision and hope they get the paper published soon. I am looking forward to read the publications with results from this project, once completed.
REVIEWER
Ryuma Shineha Seijo University, Japan REVIEW RETURNED 04-Sep-2018
GENERAL COMMENTS
The making protocols shown in this article is valuable and should be progressed more and more. In the course of the making protocols, the perspectives of healthcare experts need to be implemented. In addition, the viewpoint to cultivate the healthcare students is important. Therefore, the aim of this article should be accepted. Considering these general comments, a reviewer would like to show some point for revision as below:
1. For this protocol for systematic literature review, are databases referenced in this article enough? This article try to include perspectives of various social factors and implications of previous studies in humanities and social sciences. Under this direction, it seems that articles in JSTOR, EBSCO, and other databases related to social sciences and humanities should also be analyzed.
2.
If authors would like to answer sub-question (a), authors seem to consider implications of previous studies focusing on SCR/T in sociology and social psychology. This point relates to the first comment. 3.
Although this article focus on healthcare expert and healthcare student, is there no necessary to consider previous studies analyzing recognition and attitudes toward SCR/T in more broader actors including the public? There are studies which consider the various attitudes and value toward SCR/T in European countries (e.g. UK, Germany, etc), Japan, USA, and etc. Some researches tried to compare attitudes to SCR/T between the public and experts. If including previous studies focusing biotechnology more broadly, there are more researches. If authors try to generalize their their discussions broader and broader to other various biomedical fields, these previous studies will be help to make authors' analysis and discussion.
VERSION 1 -AUTHOR RESPONSE

Reviewer 1's Comments
Authors' Response (1) "Perceptions" -the investigations of "perceptions" plays a central role in the paper, but the concept is not conceptualized. Does the term refer to attitudes, opinions, viewpoints, knowledge, values, understandings of medical concepts, moral considerations, scruples, situated understandings of ethics, embodied sensibilities, or interpretations of medical experiences (or any other). This should be clarified.
Thank you for your comment. We initially struggled to define exactly what we would include under people's perceptions of SCR/T, but we have now come to a broad but functional definition, which we explain on pages 5 of the revised protocol:
"This review focuses on particular individuals' perceptions of SCR/T. By perceptions we broadly mean individuals' opinions and views in terms of what they think about SCR/T and what they understand SCR/T to be, individuals' attitudes and values towards SCR/T (e.g. their moral considerations and understandings of ethical dilemmas concerning SCR/T), and individuals' personal experiences with and interpretations of SCR/T." (2) Moreover, the "objects" of the perceptions that the project aims to review should be defined in greater detail. Or, to put it differently, the focus of the protocol should be sharpened. Let me explain this by referring to (i) the perceptions of "donors" and "donation" and (i) the perceptions about "stem cell research and developing therapies" Please see our responses below.
(i) Perceptions of donors: -Which types of donors / donors of which types of tissues is the protocol referring to? There are obviously huge differences of donors (and the perceptions of donors) donating embryos and ova, or donors donating bone marrow, blood cells. Each of these forms of donation has its own challenges and set of ethical dilemmas. Will you review literature related to all of these forms of donation? (This would presumably be a review project in its own rights). A selection seems recommendable. This needs to be pointed out. -Speaking about donors: I have just published an article with a Chinese scholar on Thank you for this recommendation and request for clarity. While we acknowledge that these different donor groups all face issues and concerns specific to their donation situation, in our initial literature search we have found that particularly articles looking at the donation of extra ovas or embryos from infertility treatments, do not specify that the donation is for SCR, but rather just for research. Therefore, we will exclude studies that do not specifically look at donation for SC related research or treatment. We will also include studies that look at the perception of bone marrow and blood cell donors, which at this stage we have not found many of. We have now clarified this in the "Donors will include individuals who donate ovas or embryos specifically for SCR (with this clearly stated in the studies being reviewed) and those who donate blood or bone marrow to SCR/T."
Thank you for bringing our attention to your recently published article. As we currently only plan to include articles published up to 2017, at this time your article cannot be included in our review, but I'm sure it will help inform our larger research project.
(ii) Perceptions "about stem cell research and developing therapies" It would be good to briefly clarify what exactly is meant by "stem cell research" and "developing therapies".
Thank you for bringing this concern to our attention. We do not intend to limit the topics related to SCR/T that this review covers as we aim to cover a wide breath of topics in order to better understand the concerns and opinions people have about these topics. We understand that not limiting the topics we cover may raise concerns about the feasibility of the review given the large number of papers we may find. However, an initial screening of the articles revealed that the number of articles that meet all of our inclusion criteria is a manageable number for a qualitative review. Also, we are already discussing dividing the results from the review between two papers, one on research and the other on treatment.
Saying this we have added a section to the Eligibility Criteria section that explains what topics we will cover in the review: "This review will consider stem cell research and therapies that use various cell types (embryonic, adult, mesenchymal, and induced pluripotent cells), as well as both well established, government regulated SCT and experimental therapies. The review will explore perceptions on topics from the utilization of embryos in SCR to patients' use of experimental therapies. It will also include the issue of establishing "legitimate" research centers and competition between researchers. In other words, we do not intent to limit the topics related to perceptions on SCR/T that are covered in this review. Our aim is to gain a broad understanding of the topics with which the target population is concerned and their views on these specific topics. " (page 5 of the revised review) (3) The geographic dimensions of perceptions of SCR and therapies Thank you for your comment. We do not intend to limit the review geographically; rather we will include studies published in the languages we Clarification of the geographic focus of the study seems appropriate and necessary. Rather than stating -we focus on studies published in Chinese, English, Spanish and Slovenian -I suggest to say: "we include studies that have examined perceptions of SCR and therapies in the following countries: country a, b, c, etc. This is not only more accurate but it also avoids ambiguities (for example, literature in Chinese can both refer to empirical studies in China, Taiwan, Hong Kong, Singapore, but potentially also any other part of the world).
can read from any part of the world. We have rewritten this section to make this more clear:
"In order to gain a global understanding of perceptions of SCR/T, the setting in which studies took place will not be limited by region or country. However, studies will be limited by publication language given the language skills of the research team. Thus, studies published in Chinese, English, Slovenian, and Spanish will be included" (page 5 of the revised manuscript).
Furthermore, as our research team is based in Taiwan this is partly why we have decided to include a Chinese data based, but also because we know various studies have been published related to our topic from research conducted in China, Hong Kong, and Taiwan.
Rosemann, A., Barfoot, J., and C. Blackburn BMJ Open only publishes study protocols for research that is in the planning or early research stages. Our study is underway but we are still collecting literature to include in the review. Thus, we appreciate you pointing us to more literature. We will review these articles and add them to our review if they meet the inclusion criteria. Thank you for your comments. We do worry that through the coding process the wider contextual setting of the study may be overlooked, presenting a limitation. However, we do intend to take into consideration the specific context of each included study during the final analysis stage when we compare the studies looking at study population and context. In doing this we hope to overcome the initial limitation.
The bullet point in question has now been rewritten:
"By removing data from the context of the original study it will no longer be connected to the context of the original research questions or setting presenting an analytical limitation; however, in the final stage of the analysis the study context will be considered during cross study comparison." (page 2 of the revised protocol). Or do you refer to differences in perceptions that exist between (and also within these groups)? For example: how the views of patients influence understandings of medics? o And who is relaying information to whom in this question? Donors to medics, medics to patients, patients to clinical researchers? -These issues should be addressed. This sub-question should be sharpened or maybe divided into two (but substantially reformulated).
Thank you for your comment and for urging us to clarify our research questions. Subquestion b intended to address your second interpretation of the question. We have now rewritten the question which required it to be divided into two subquestions:
b. What are the differences in the perceptions that exist between and within these stakeholder groups, and in which ways do thier varying perceptions influence the perceptions of those in other stakeholder groups? c. How do perceptions around stem cell research and developing therapies influence the information that particular stakeholders relay to others?
Please see page 4 of the revised protocol. "This systematic review protocol was developed in accordance with the Preferred Reporting Items for Systematic Review and Meta Analysis Protocols (PRISMA-P) guidelines, which intend to assist researchers in developing the rationale for their review or meta-analysis, and pre-plan the methodological and analytical approaches they will utilize." (please see page 4 of the revised protocol) To sum up: I do think this protocol paper should be published, after addressing the above points. In essence many of the issues are raised do not require much work. I would like to wish the authors the best of luck with their revision and hope they get the paper published soon. I am looking forward to read the publications with results from this project, once completed.
Thank you again for your insightful comments and suggestions, which have helped us further focus our systematic review.
Reviewer 2's Comments
Authors' Response For this protocol for systematic literature review, are databases referenced in this article enough? This article try to include perspectives of various social factors and implications of previous studies in humanities and social sciences. Under this direction, it seems that articles in JSTOR, EBSCO, and other databases related to social sciences and humanities should also be analyzed.
Thank you for your recommendation. We have considered that we may miss some articles related to particular stakeholders' perceptions of SCR/T by searching the included databases, this is why in the Literature Search section (page 4 and 5 of the revised protocol) we explain that we will also search specific social science journals and the reference lists of the articles that we include in the review. Moreover, we will include specific key texts from STS, sociology, and anthropology that the research team has already identified.
If the reviewer or the editor feel it is necessary we can include a supplement that lists the journals we will include in the additional search. If authors would like to answer sub-question (a), authors seem to consider implications of previous studies focusing on SCR/T in sociology and social psychology. This point relates to the first comment.
Thank you for your comment. Please see our previous response to your question about the search sources.
Thank you for your recommendation. This systemically literature review is part of a larger study exploring how healthcare educators' perceptions of SCR/T impacts the learning of healthcare students. Therefore, this systematic review is specifically concerned with the perceptions of individuals who work in or visit healthcare facilities (e.g. healthcare personnel, healthcare students, patients and their families/caregivers, donors, and possibly researchers/scientist). We acknowledge that these stakeholders' perceptions of SCR/T may be influenced by discussions happening in the media and/or politically, as well as by larger socio-cultural constructs (such as religion and family dynamics), and we aim to explore these factors through the perceptions of these stakeholders. This is why we will exclude studies that specifically focus on the media's or governments' perceptions of SCR/T.
In the section now titled "Defining the Inclusion Criteria" we now make it more explicit that the population being included in the review includes individuals who may be present in the healthcare setting. Please see page 5 of the revised protocol.
